Concepedia

David Fitchett

DF

Statistics

Publications

103

Citations

22.5K

H-Index

45

Active since

1975

Affiliations

University of Toronto(Current)

St. Michael's Hospital

Canadian Heart Research Centre

Mount Sinai Hospital

Lunenfeld-Tanenbaum Research Institute

David Fitchett is an author at University of Toronto specializing in medicine, cardiovascular disease, and cardiology.

ORCID

Top concepts

Publications per year

1975–2022

103

Publications

103

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 11.6K citations · Full text

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Christoph Wanner, Silvio E. Inzucchi, John M. Lachin et al. · New England Journal of Medicine · 2016 · 3.5K citations · Full text

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

Silvio E. Inzucchi, Bernard Zinman, David Fitchett et al. · Diabetes Care · 2017 · 721 citations

Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Subodh Verma, C. David Mazer, Andrew T. Yan et al. · Circulation · 2019 · 550 citations

Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial

David Fitchett, Silvio E. Inzucchi, Christopher P. Cannon et al. · Circulation · 2019 · 342 citations · Full text

1–5 of 103